Trevi Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 11.37 M | $48.85 M | 0.00% | 11.25% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 10.66 M | $43.94 M | 44.49% | 10.55% |
| VIKING GLOBAL INVESTORS LP | 02/14/2025 | 4.40 M | $18.13 M | 0.00% | 4.35% |
| RUBRIC CAPITAL MANAGEMENT LP | 02/14/2025 | 4.21 M | $17.33 M | -16.35% | 4.16% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 4.15 M | $17.10 M | 100.00% | 4.11% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.93 M | $16.19 M | 21.94% | 3.89% |
| VANGUARD GROUP INC | 02/11/2025 | 3.51 M | $14.46 M | 7.57% | 3.47% |
| VIVO CAPITAL, LLC | 02/13/2025 | 3.49 M | $14.37 M | 116.25% | 3.45% |
| WOODLINE PARTNERS LP | 02/14/2025 | 3.21 M | $13.24 M | 429.93% | 3.18% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 3.09 M | $12.75 M | 101.16% | 3.06% |
| SIREN, L.L.C. | 02/14/2025 | 2.91 M | $11.97 M | 100.00% | 2.88% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 2.50 M | $10.30 M | 100.00% | 2.47% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 2.32 M | $9.55 M | -9.75% | 2.29% |
| 02/14/2025 | 2.00 M | $8.24 M | 100.00% | 1.98% | |
| MAI CAPITAL MANAGEMENT | 02/14/2025 | 1.36 M | $5.59 M | 2.23% | 1.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.30 M | $5.35 M | 2.78% | 1.29% |
| VR ADVISER, LLC | 02/14/2025 | 1.27 M | $5.22 M | -63.00% | 1.25% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 1.25 M | $5.15 M | -54.55% | 1.24% |
| CHECKPOINT CAPITAL L.P. | 02/14/2025 | 1.08 M | $4.47 M | 333.65% | 1.07% |
| ROSALIND ADVISORS, INC. | 02/14/2025 | 1.06 M | $4.38 M | 41.67% | 1.05% |
| ALLY BRIDGE GROUP (NY) LLC | 02/14/2025 | 781,489 | $3.22 M | -40.92% | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 771,958 | $3.18 M | 165.73% | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 734,234 | $3.03 M | 52.15% | 0.73% |
| J. GOLDMAN & CO LP | 02/14/2025 | 537,609 | $2.21 M | 261.01% | 0.53% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 325,000 | $1.34 M | 100.00% | 0.32% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 236,144 | $972,913 | 43.78% | 0.23% |
| JPMORGAN CHASE & CO | 02/12/2025 | 221,664 | $913,256 | 120.52% | 0.22% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 180,419 | $743,326 | 774.93% | 0.18% |
| J. GOLDMAN & CO LP | 02/14/2025 | 178,800 | $736,656 | 45.13% | 0.18% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 177,481 | $731,222 | -4.31% | 0.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 173,063 | $713,020 | 14.67% | 0.17% |
| BARCLAYS PLC | 02/13/2025 | 156,267 | $643,000 | 64.09% | 0.15% |
| TEJARA CAPITAL LTD | 02/10/2025 | 153,739 | $633,405 | -36.37% | 0.15% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 140,219 | $577,703 | 2.14% | 0.14% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 135,807 | $559,525 | 100.00% | 0.13% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 134,353 | $553,436 | 86.06% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 131,500 | $541,780 | 100.00% | 0.13% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 120,304 | $495,652 | 383.13% | 0.12% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 120,212 | $495,000 | -1.83% | 0.12% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 100,400 | $413,648 | 42.01% | 0.10% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 100,000 | $412,000 | 100.00% | 0.10% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 96,784 | $398,750 | 187.05% | 0.10% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 96,350 | $396,962 | 0.00% | 0.10% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 93,859 | $386,699 | 100.00% | 0.09% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 89,309 | $367,953 | 100.00% | 0.09% |
| OPPENHEIMER & CO INC | 02/05/2025 | 81,403 | $335,380 | -0.66% | 0.08% |
| RHUMBLINE ADVISERS | 01/30/2025 | 79,874 | $329,072 | -2.56% | 0.08% |
| PFS PARTNERS, LLC | 01/27/2025 | 79,000 | $325,480 | 0.00% | 0.08% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 78,143 | $321,949 | 44.74% | 0.08% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 70,317 | $289,706 | 100.00% | 0.07% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Trevi Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 113 institutional investors and hedge funds held shares of Trevi Therapeutics, Inc.. The most heavily invested institutionals were:
NEA Management Company, LLC: 11.37 M
Frazier Life Sciences Management, L.P.: 10.66 M
VIKING GLOBAL INVESTORS LP: 4.4 M
Rubric Capital Management LP: 4.21 M
Point72 Asset Management, L.P.: 4.15 M
BlackRock Funding, Inc. /DE: 3.93 M
78.64% of Trevi Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 83.09 M shares in the last 24 months. This purchase volume represents approximately $358.95 M in transactions.